Daliap, Mitchelo L.

HRN: 09-38-21  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2022
CEFUROXIME 1.5GM (VIAL)
08/22/2022
08/28/2022
IV
900mg
Q8Hrs
Tc SVI R/i DF
Waiting Final Action 
08/22/2022
CEFTRIAXONE 1G (VIAL)
08/22/2022
08/28/2022
IV
1gram
Q12hrs
Typhoid Fever
Waiting Final Action 
08/25/2022
CEFIXIME 200MG (CAP)
08/25/2022
08/31/2022
PO
200mg
BID
Typhoid Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: